---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-081608"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:32:49.012497+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tivic Health receives Nasdaq delisting notice for bid price below $1.00 for 33 days

## Summary
- Received Nasdaq deficiency letter on June 28, 2024 for non-compliance with minimum bid price requirement.
- Closing bid price below $1.00 per share for 33 consecutive business days.
- 180-day cure period ends December 26, 2024; must close at or above $1.00 for 10 consecutive days.
- If not compliant by deadline, may request a second 180-day period if other listing standards are met.
- Listing remains fully effective during cure period; company evaluating options to regain compliance.

## SEC filing metadata
- accession: 0000950170-24-081608
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017024081608/0000950170-24-081608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017024081608/tivc-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-081608
- JSON: https://secwatch.observer/filing/0000950170-24-081608.json
- Plain text: https://secwatch.observer/filing/0000950170-24-081608.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.